Morohashi, Tamaki http://orcid.org/0000-0002-3965-9852
Hayashi, Takaaki http://orcid.org/0000-0002-1535-0279
Mizobuchi, Kei http://orcid.org/0000-0001-5389-6507
Nakano, Tadashi
Morioka, Ichiro http://orcid.org/0000-0002-5685-2670
Funding for this research was provided by:
Santen
Alcon
Johnson and Johnson Vision
Daiichi-Sankyo
Chugai Pharmaceutical
Mitsubishi Tanabe Pharma Corporation
Senju
Bayer
Kyowa Hakko Kirin
Otsuka Pharmaceutical
Kowa Company
Ritz medical
Kuribara
Article History
Received: 15 September 2022
Accepted: 13 December 2022
First Online: 27 December 2022
Declarations
:
: Takaaki Hayashi received research funds from Santen (Osaka, Japan), Alcon (Tokyo, Japan), Johnson and Johnson Vision, AMO (Tokyo, Japan), Daiichi Sankyo (Tokyo, Japan), Chugai (Tokyo, Japan), Mitsubishi Tanabe Pharma (Osaka, Japan), Senju (Osaka, Japan), Bayer (Osaka, Japan), Kyowa Kirin (Tokyo, Japan), Otsuka Pharma (Tokyo, Japan), Kowa (Aichi, Japan), Ritz medical (Aichi, Japan), Uni-hite (Kanagawa, Japan), and Kuribara (Gunma, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: This article does not contain any studies with animals performed by any of the authors.
: Written informed consent was obtained from the patient's parents for publication of this case report.